Oligo Blog

Sustainability is becoming an increasingly important consideration across the pharmaceutical value chain — including the manufacturing of..

Nucleic acid therapeutics hold immense promise and getting them where they need to go remains one of biotechnology’s greatest challenges. Their size..

Join us for our upcoming live webinar on Tuesday, September 22, 2026, where Nils Schomann, QC Manager Method Development, will explore the..

What happens when cutting-edge RNA science meets Hollywood? Apparently, you get Spider-Man discussing siRNA with Bruce Banner.

In Spider-Man: Brand..

RNA interference, or RNAi, is a natural cellular mechanism that helps regulate gene expression. Small interfering RNA, or siRNA, therapies use this..

Every medicine has a story. For nucleic acid therapeutics, drugs based on DNA or RNA molecules, the journey is both complex and inspiring. Starting..

It's the people behind BioSpring who make the difference. Every team member brings unique experiences, skills, and perspectives that strengthen our..

Free Webinar: This expert presentation addresses key manufacturing challenges in therapeutic oligonucleotide production as programs scale toward..

What sets BioSpring apart is its people. Each team member contributes unique perspectives, experiences, and expertise, creating the foundation for..

Great results don't happen by chance—they're built on the right expertise. Let's take a closer look at one of the services that helps our customers..